KDR and hemangioma: Propranolol inhibits the activation of βARs and regulates their downstream signal transduction pathways, such as cAMP, VEGFR2, PI3K-AKT-mTOR, and MAPK, thereby inhibiting the proliferation of hemangioma endothelial cells and inducing apoptosis [23].